QUINT (QUINT) Reaches 24 Hour Volume of $204,771.14

Bright Minds Biosciences Inc. (NASDAQ:DRUG – Get Rating) was the target of a large increase in short interest in April. As of April 30th, there was short interest totalling 675,000 shares, an increase of 38.1% from the April 15th total of 488,600 shares. Approximately 4.7% of the shares of the stock are short sold. Based […]

Related Keywords

,Bright Minds Biosciences Company Profile ,Virtu Financial ,Nasdaq ,Bright Minds Biosciences Inc ,Advisorshares Investments ,Bright Minds Biosciences ,Get Rating ,Bright Minds ,Shares Investments ,Jane Street Group ,Minds Biosciences ,Minds Biosciences Inc ,Bright Minds Biosciences Daily ,Nasdaq Drug ,Drug ,Medical ,Stocks ,Options ,Put ,Call ,